Quizartinib | m-entrepreneurship.com

Product Name :
Quizartinib

Search keywords :
Quizartinib

drugId :
null

Target Vo:
Tyrosine-protein kinase receptor FLT3

Target Vo Short Name :
FLT3

Moa_Name:
Tyrosine-protein kinase receptor FLT3 inhibitors

First Approval Country :
Japan

First Approval Date Filter:
2019

Origin Company_Name :
Ambit Biosciences Co

Active Company_Name :
Cardiff University

Active Indication_Name:
Leukemia, Myeloid, Acute

In Active Indication_Name:
Precursor Cell Lymphoblastic Leukemia-Lymphoma

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Phase 3 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
STAT3 Rabbit mAb Biological Activity
Fibronectin Rabbit mAb Technical Information
Bid Antibody: Bid Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 22 kDa, targeting to Bid. It can be used for WB,ICC/IF,IHC-P,FC,IP assays with tag free, in the background of Human.

Author: Betaine hydrochloride

Related Posts